Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 钠通道 / SLC13A5-IN-1

SLC13A5-IN-1 {[allProObj[0].p_purity_real_show]}

货号:A1250015

SLC13A5-IN-1是一种选择性 SLC13A5 抑制剂,具有潜在的应用于代谢和心血管疾病的研究。

SLC13A5-IN-1 化学结构 CAS号:2227548-95-8
SLC13A5-IN-1 化学结构
CAS号:2227548-95-8
SLC13A5-IN-1 3D分子结构
CAS号:2227548-95-8
SLC13A5-IN-1 化学结构 CAS号:2227548-95-8
SLC13A5-IN-1 3D分子结构 CAS号:2227548-95-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

SLC13A5-IN-1 纯度/质量文件 产品仅供科研

货号:A1250015 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >
产品名称 Sodium Channel 其他靶点 纯度
Tolperisone HCl 99%
Lamotrigine 98%
Vinpocetine 98%
Zonisamide 98%
Dronedarone Hydrochloride 95%
Procainamide hydrochloride 99%
Bupivacaine HCl 99+%
Benzocaine 98%
Carbamazepine ++

Sodium channel, IC50: 131 μM

98%
Ibutilide fumarate 99%+
Dibucaine HCl 99+%
Mexiletine HCl 99%
Phenytoin 99+%
Camostat Mesylate +++

epithelial sodium channel (ENaC), IC50: 50 nM

99%+
Levobupivacaine 97+%
Oxcarbazepine +

sodium channel, IC50: 160 μM

98%
Ambroxol 98+%
Primidone 99%
Propafenone 99%
A-803467 ++++

Na(V1.8) channel, IC50: 8 nM

99%+
Rufinamide 99%
Phenytoin sodium 98%
Proparacaine Hydrochloride +

Voltage-gated sodium channel, ED50: 3.4 mM

98+%
Riluzole 97%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

SLC13A5-IN-1 生物活性

描述 SLC13A5-IN-1 is a specific inhibitor of the sodium-citrate co-transporter (SLC13A5). It completely inhibits the uptake of 14C-citrate in HepG2 cells, with an IC50 value of 0.022 μM. SLC13A5-IN-1 shows promise for the treatment of metabolic and/or cardiovascular diseases. This compound is derived from patent WO2018104220A1, specifically Compound I-5[1].
体外研究

In the HepG2/14C-Citrate Uptake Assay, SLC13A5-IN-1 demonstrates an IC50 value of 0.022 μM. HepG2 cells express endogenous hSLC13A5 transporter, responsible for citrate uptake. The uptake of 14C-citrate can be fully inhibited by SLC13A5-IN-1, and the signal can be competed with unlabeled citrate[1].

In the recombinant hSLC3A5/14C-Citrate Uptake Assay, SLC13A5-IN-1 demonstrates an IC50 value of 0.056 μM[1].

In the recombinant Human GlyT2/3H-Glycine Uptake Assay, SLC13A5-IN-1 demonstrates an IC50 value of 100 μM. Human embryonic kidney 293 cells stably overexpressing the human GlyT2 receptor, responsible for glycine uptake, are utilized. The uptake of 3H-glycine can be entirely inhibited by SLC13A5-IN-1[1].

SLC13A5-IN-1 参考文献

[1]Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1

SLC13A5-IN-1 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.83mL

2.17mL

1.08mL

21.65mL

4.33mL

2.17mL

SLC13A5-IN-1 技术信息

CAS号2227548-95-8
分子式C19H19Cl3N2O3S
分子量 461.79
别名
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,2-8°C

溶解度

DMSO: 12 mg/mL(25.99 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。